Dissemin
Language
العربيّة
Deutsch
English
Español
Suomi
Français
한국어
Македонски
Português
Português Brasileiro
Русский
Svenska
Türkçe
简体中文
繁體中文
Login
Dissemin
Matteo S. Carlino
Schuler et al., 2017
Links
ORCID
Tools
Export citation
×
Format
BibTeX
@misc{Schuler2017, author = {Schuler, Martin H. and Ascierto, Paolo A. and De Vos, Filip Yves Francine Leon and Postow, Michael Andrew and Van Herpen, Carla Ml and Carlino, Matteo S. and Sosman, Jeffrey A. and Berking, Carola and Long, Georgina and Weise, Amy}, month = {jan}, title = {Phase 1b/2 trial of ribociclib+ binimetinib in metastatic NRAS-mutant melanoma: Safety, efficacy, and recommended phase 2 dose (RP2D).}, year = {2017} }
Export citation
Search in Google Scholar
Phase 1b/2 trial of ribociclib+ binimetinib in metastatic NRAS-mutant melanoma: Safety, efficacy, and recommended phase 2 dose (RP2D).
Published in 2017 by
Martin H. Schuler
,
Paolo A. Ascierto
,
Filip Yves Francine Leon De Vos
,
Michael Andrew Postow
,
Carla Ml Van Herpen
,
Matteo S. Carlino
,
Jeffrey A. Sosman
,
Carola Berking
,
Georgina Long
,
Amy Weise
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text:
Unavailable
Preprint
: policy unknown
Upload
Postprint
: policy unknown
Upload
Published version
: policy unknown
Upload